Literature DB >> 7936253

The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease.

D Galasko1, T Saitoh, Y Xia, L J Thal, R Katzman, L R Hill, L Hansen.   

Abstract

We determined apolipoprotein E (ApoE) genotypes in 122 autopsied demented patients. The frequency of the ApoE epsilon 4 allele was 39.6% in Alzheimer's disease (AD), 29.0% in the Lewy body variant of AD (LBV), and 6.25% in diffuse Lewy body disease. For AD and LBV patients, the epsilon 4 frequency was significantly higher than that reported in nondemented controls (10 to 15%). Therefore, LBV and AD share ApoE epsilon 4 as a genetic risk factor, providing further evidence that these conditions overlap.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7936253     DOI: 10.1212/wnl.44.10.1950

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  20 in total

1.  Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease.

Authors:  D W Tsuang; R K Wilson; O L Lopez; E K Luedecking-Zimmer; J B Leverenz; S T DeKosky; M I Kamboh; R L Hamilton
Journal:  Neurology       Date:  2005-02-08       Impact factor: 9.910

2.  Twin pairs discordant for neuropathologically confirmed Lewy body dementia.

Authors:  C Sheei-Meei Wang; J R Burke; D C Steffens; C M Hulette; J C S Breitner; B L Plassman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-05       Impact factor: 10.154

3.  Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia.

Authors:  L A Hansen; S E Daniel; G K Wilcock; S Love
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-05       Impact factor: 10.154

Review 4.  Interaction of apolipoprotein E epsilon 4 with other genetic and non-genetic risk factors in late onset Alzheimer disease: problems facing the investigator.

Authors:  R Katzman; D Kang; R Thomas
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

Review 5.  Lewy Body Disease: Clinical and Pathological "Overlap Syndrome" Between Synucleinopathies (Parkinson Disease) and Tauopathies (Alzheimer Disease).

Authors:  Clovis Foguem; Patrick Manckoundia
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-08       Impact factor: 5.081

6.  Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson's disease.

Authors:  A S Whitehead; S Bertrandy; F Finnan; A Butler; G D Smith; Y Ben-Shlomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

7.  Association of apolipoprotein epsilon 4 allele and neuropathologic findings in patients with dementia.

Authors:  M G Martinoli; J Q Trojanowski; M L Schmidt; S E Arnold; T M Fujiwara; V M Lee; H Hurtig; J P Julien; C Clark
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  APOE ε4 increases risk for dementia in pure synucleinopathies.

Authors:  Debby Tsuang; James B Leverenz; Oscar L Lopez; Ronald L Hamilton; David A Bennett; Julie A Schneider; Aron S Buchman; Eric B Larson; Paul K Crane; Jeffrey A Kaye; Patricia Kramer; Randy Woltjer; John Q Trojanowski; Daniel Weintraub; Alice S Chen-Plotkin; David J Irwin; Jacqueline Rick; Gerard D Schellenberg; G Stennis Watson; Walter Kukull; Peter T Nelson; Gregory A Jicha; Janna H Neltner; Doug Galasko; Eliezer Masliah; Joseph F Quinn; Kathryn A Chung; Dora Yearout; Ignacio F Mata; Jia Y Wan; Karen L Edwards; Thomas J Montine; Cyrus P Zabetian
Journal:  JAMA Neurol       Date:  2013-02       Impact factor: 18.302

9.  Age and apoE associations with complex pathologic features in Alzheimer's disease.

Authors:  Gregory A Jicha; Joseph E Parisi; Dennis W Dickson; Ruth H Cha; Kris A Johnson; Glenn E Smith; Bradley F Boeve; Ronald C Petersen; David S Knopman
Journal:  J Neurol Sci       Date:  2008-07-23       Impact factor: 3.181

10.  Comparison of clinical manifestations in Alzheimer disease and dementia with Lewy bodies.

Authors:  Angela Nervi; Christiane Reitz; Ming-Xin Tang; Vincent Santana; Angel Piriz; Dolly Reyes-Dumeyer; Rafael Lantigua; Martin Medrano; Ivonne Z Jiménez-Velázquez; Joseph H Lee; Richard Mayeux
Journal:  Arch Neurol       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.